SEC Form 4 · accession 0001209191-15-027749
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David C Dreyer
Officer — SVP / Chief Financial Officer
Period of report
Mar 9, 2015
Accepted (ET)
Mar 19, 2015 · 1:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.99 | Mar 9, 2015 | A | 871,710 | A | — | Mar 9, 2025 | Common Stock | 871,710 | 871,710 | D |
Explanation of responses
- F1The stock option vests as follows: 130,757 of the option shares shall vest and be exercisable on the one-year anniversary of the Reporting Person's first date of employment; 10,896 of the option shares shall vest and be exercisable on each one-month anniversary following the one-year anniversary for a period of 35 consecutive months; 10,909 of the option shares shall vest and be exercisable on the 36-month anniversary; and 348,684 option shares shall vest and be exercisable on March 9, 2025, subject to the Reporting Person's continued service with the Company through the applicable vesting dates.